ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

19 links0 made here, not in the record36 judgments2 judges (the rules as one: Rule based)0 record changes seen
Claude Opus 5.5Rule based
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT04185883Sotorasib Activity inSubjects With AdvancedSolid Tumors With KRASp.G12C Mutation (CodeBreak101)AmgenPhase 1 · active not recruitinRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSAdvanced Solid TumorsNo longer in the registry's filing›Nov 14 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseKirsten Rat Sarcoma (KRAS) …No longer in the registry's filing›Nov 14 · Rule based · Not readNot readDRUGSSotorasibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedTrametinibIntervention entry›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundVociprotafibEntry “RMC-4630”, read by our name ru…›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · BackgroundTestedAfatinibIntervention entry›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundPembrolizumabIntervention entry›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundPanitumumabIntervention entry›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundCarboplatinEntry “Carboplatin, pemetrexed, docet…›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundPemetrexedEntry “Carboplatin, pemetrexed, docet…›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundDocetaxelEntry “Carboplatin, pemetrexed, docet…›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundPaclitaxelEntry “Carboplatin, pemetrexed, docet…›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundAtezolizumabIntervention entry›Nov 3 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · BackgroundBackground · partnerPalbociclibIntervention entry›Nov 3 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · BackgroundBackground · partnerINT033193Entry “MVASI® (bevacizumab-awwb)”, re…›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundBatoprotafibEntry “TNO155”, read by our name rule›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · BackgroundTestedPan-KRAS Inhibitor BI 17019…Entry “BI 1701963”, read by our name …›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · BackgroundTestedZeluvalimabEntry “AMG 404”, read by our name rule›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · BackgroundTestedEverolimusIntervention entry›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Sotorasib

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Sotorasib”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 3SotorasibClaude Opus 5.5TestedCurrent
Nov 3TrametinibClaude Opus 5.5BackgroundCurrent
Nov 3VociprotafibClaude Opus 5.5TestedCurrent
Nov 3AfatinibClaude Opus 5.5BackgroundCurrent
Nov 3PembrolizumabClaude Opus 5.5BackgroundCurrent
Nov 3PanitumumabClaude Opus 5.5BackgroundCurrent
Nov 3CarboplatinClaude Opus 5.5BackgroundCurrent
Nov 3PemetrexedClaude Opus 5.5BackgroundCurrent
Nov 3DocetaxelClaude Opus 5.5BackgroundCurrent
Nov 3PaclitaxelClaude Opus 5.5BackgroundCurrent
Nov 3AtezolizumabClaude Opus 5.5Background · partnerCurrent
Nov 3PalbociclibClaude Opus 5.5Background · partnerCurrent
Nov 3INT033193Claude Opus 5.5BackgroundCurrent
Nov 3BatoprotafibClaude Opus 5.5TestedCurrent
Nov 3Pan-KRAS Inhibitor BI 1701963Claude Opus 5.5TestedCurrent
Nov 3ZeluvalimabClaude Opus 5.5TestedCurrent
Nov 3EverolimusClaude Opus 5.5BackgroundCurrent
Nov 14Advanced Solid TumorsRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 14Kirsten Rat Sarcoma (KRAS) pG12C MutationRule based · condition-kind ruleNot readCurrent
Nov 18SotorasibRule based · role ruleTestedAgrees
Nov 18TrametinibRule based · role ruleBackgroundAgrees
Nov 18VociprotafibRule based · role ruleBackgroundOverridden
Nov 18AfatinibRule based · role ruleBackgroundAgrees
Nov 18PembrolizumabRule based · role ruleBackgroundAgrees
Nov 18PanitumumabRule based · role ruleBackgroundAgrees
Nov 18CarboplatinRule based · role ruleBackgroundAgrees
Nov 18PemetrexedRule based · role ruleBackgroundAgrees
Nov 18DocetaxelRule based · role ruleBackgroundAgrees
Nov 18PaclitaxelRule based · role ruleBackgroundAgrees
Nov 18AtezolizumabRule based · role ruleBackgroundAgrees
Nov 18PalbociclibRule based · role ruleBackgroundAgrees
Nov 18INT033193Rule based · role ruleBackgroundAgrees
Nov 18BatoprotafibRule based · role ruleBackgroundOverridden
Nov 18Pan-KRAS Inhibitor BI 1701963Rule based · role ruleBackgroundOverridden
Nov 18ZeluvalimabRule based · role ruleBackgroundOverridden
Nov 18EverolimusRule based · role ruleBackgroundAgrees

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.